ArticleRMD open2023

Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association.

Michelle D van den Beukel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.